Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting
1
Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria
2
School of Pharmaceutical Sciences Geneva-Lausanne, University of Geneva, Quai Ernest-Ansermet 30, CH-1211, Geneva, Switzerland
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 190; https://doi.org/10.3797/scipharm.oephg.21.SL-23
Submission received: 16 April 2009
/
Accepted: 16 April 2009
/
Published: 16 April 2009
Abstract
Background: Bladder cancer is one of the most common malignancies. Advances have been made in diagnosis, therapy, and surveillance resulting in increasing survival rates of patients, but the search for more effective therapies is imperative to be continued. Among others, lectin-mediated targeting might be a promising concept. Thus, the potential of fluorescein-labeled plant lectins was investigated using 5637 cells as a model for human urinary carcinoma [1] and SV-HUC-1 cells as a model for non-tumorigenic human uroepithelial cells.
Share and Cite
MDPI and ACS Style
PLATTNER, V.E.; GABOR, F.; BORCHARD, G.; WIRTH, M. Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting. Sci. Pharm. 2009, 77, 190. https://doi.org/10.3797/scipharm.oephg.21.SL-23
AMA Style
PLATTNER VE, GABOR F, BORCHARD G, WIRTH M. Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):190. https://doi.org/10.3797/scipharm.oephg.21.SL-23
Chicago/Turabian StylePLATTNER, V. E., F. GABOR, G. BORCHARD, and M. WIRTH. 2009. "Differences in the Glycocalyx of 5637 and SV-HUC-1 Cells and their Impact on Lectin Targeting" Scientia Pharmaceutica 77, Short Lectures (SL): 190. https://doi.org/10.3797/scipharm.oephg.21.SL-23
